The global market for Peptide CXO was valued at US$ 3211 million in the year 2024 and is projected to reach a revised size of US$ 6459 million by 2031, growing at a CAGR of 10.6% during the forecast period.

Peptide CXO Market

Peptide CXO refers to the outsourcing of research, development, manufacturing, and commercialization processes of peptide-based drugs to specialized Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), and Contract Manufacturing Organizations (CMOs). These services include peptide synthesis optimization, process development, quality control, clinical research, regulatory submissions, and large-scale production. The Peptide CXO model helps pharmaceutical companies reduce R&D and manufacturing costs, accelerate time-to-market, and ensure the quality and stability of peptide drug supply chains.

North American market for Peptide CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Peptide CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Peptide CXO in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Peptide CXO include Polypeptide, Bachem, LONZA, Bicycle, Pepscan, JPT Peptide, WuXi AppTec, Asymchem, Jiangsu Sinopep-Allsino Biopharmaceutical, Chinese Peptide Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Peptide CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CXO.

The Peptide CXO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide CXO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide CXO Market Report

Report Metric	Details
Report Name	Peptide CXO Market
Accounted market size in year	US$ 3211 million
Forecasted market size in 2031	US$ 6459 million
CAGR	10.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CRO CMO/CDMO
Segment by Application	Pharmaceutical Companies Biotech Companies and Research Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Polypeptide, Bachem, LONZA, Bicycle, Pepscan, JPT Peptide, WuXi AppTec, Asymchem, Jiangsu Sinopep-Allsino Biopharmaceutical, Chinese Peptide Company, AmbioPharm, ReaLi Tide Biological Technology, GL Biochem, Shenzhen JYMed Technology, Chengdu Shengnuo Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide CXO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide CXO Market growing?

Ans: The Peptide CXO Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the Peptide CXO Market size in 2031?

Ans: The Peptide CXO Market size in 2031 will be US$ 6459 million.

Who are the main players in the Peptide CXO Market report?

Ans: The main players in the Peptide CXO Market are Polypeptide, Bachem, LONZA, Bicycle, Pepscan, JPT Peptide, WuXi AppTec, Asymchem, Jiangsu Sinopep-Allsino Biopharmaceutical, Chinese Peptide Company, AmbioPharm, ReaLi Tide Biological Technology, GL Biochem, Shenzhen JYMed Technology, Chengdu Shengnuo Biotechnology

What are the Application segmentation covered in the Peptide CXO Market report?

Ans: The Applications covered in the Peptide CXO Market report are Pharmaceutical Companies, Biotech Companies and Research Institutions

What are the Type segmentation covered in the Peptide CXO Market report?

Ans: The Types covered in the Peptide CXO Market report are CRO, CMO/CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide CXO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CRO

1.2.3 CMO/CDMO

1.3 Market by Application

1.3.1 Global Peptide CXO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Biotech Companies and Research Institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide CXO Market Perspective (2020-2031)

2.2 Global Peptide CXO Growth Trends by Region

2.2.1 Global Peptide CXO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide CXO Historic Market Size by Region (2020-2025)

2.2.3 Peptide CXO Forecasted Market Size by Region (2026-2031)

2.3 Peptide CXO Market Dynamics

2.3.1 Peptide CXO Industry Trends

2.3.2 Peptide CXO Market Drivers

2.3.3 Peptide CXO Market Challenges

2.3.4 Peptide CXO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide CXO Players by Revenue

3.1.1 Global Top Peptide CXO Players by Revenue (2020-2025)

3.1.2 Global Peptide CXO Revenue Market Share by Players (2020-2025)

3.2 Global Top Peptide CXO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide CXO Revenue

3.4 Global Peptide CXO Market Concentration Ratio

3.4.1 Global Peptide CXO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide CXO Revenue in 2024

3.5 Global Key Players of Peptide CXO Head office and Area Served

3.6 Global Key Players of Peptide CXO, Product and Application

3.7 Global Key Players of Peptide CXO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide CXO Breakdown Data by Type

4.1 Global Peptide CXO Historic Market Size by Type (2020-2025)

4.2 Global Peptide CXO Forecasted Market Size by Type (2026-2031)

5 Peptide CXO Breakdown Data by Application

5.1 Global Peptide CXO Historic Market Size by Application (2020-2025)

5.2 Global Peptide CXO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide CXO Market Size (2020-2031)

6.2 North America Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide CXO Market Size by Country (2020-2025)

6.4 North America Peptide CXO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide CXO Market Size (2020-2031)

7.2 Europe Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide CXO Market Size by Country (2020-2025)

7.4 Europe Peptide CXO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide CXO Market Size (2020-2031)

8.2 Asia-Pacific Peptide CXO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide CXO Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide CXO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide CXO Market Size (2020-2031)

9.2 Latin America Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide CXO Market Size by Country (2020-2025)

9.4 Latin America Peptide CXO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide CXO Market Size (2020-2031)

10.2 Middle East & Africa Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide CXO Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide CXO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Polypeptide

11.1.1 Polypeptide Company Details

11.1.2 Polypeptide Business Overview

11.1.3 Polypeptide Peptide CXO Introduction

11.1.4 Polypeptide Revenue in Peptide CXO Business (2020-2025)

11.1.5 Polypeptide Recent Development

11.2 Bachem

11.2.1 Bachem Company Details

11.2.2 Bachem Business Overview

11.2.3 Bachem Peptide CXO Introduction

11.2.4 Bachem Revenue in Peptide CXO Business (2020-2025)

11.2.5 Bachem Recent Development

11.3 LONZA

11.3.1 LONZA Company Details

11.3.2 LONZA Business Overview

11.3.3 LONZA Peptide CXO Introduction

11.3.4 LONZA Revenue in Peptide CXO Business (2020-2025)

11.3.5 LONZA Recent Development

11.4 Bicycle

11.4.1 Bicycle Company Details

11.4.2 Bicycle Business Overview

11.4.3 Bicycle Peptide CXO Introduction

11.4.4 Bicycle Revenue in Peptide CXO Business (2020-2025)

11.4.5 Bicycle Recent Development

11.5 Pepscan

11.5.1 Pepscan Company Details

11.5.2 Pepscan Business Overview

11.5.3 Pepscan Peptide CXO Introduction

11.5.4 Pepscan Revenue in Peptide CXO Business (2020-2025)

11.5.5 Pepscan Recent Development

11.6 JPT Peptide

11.6.1 JPT Peptide Company Details

11.6.2 JPT Peptide Business Overview

11.6.3 JPT Peptide Peptide CXO Introduction

11.6.4 JPT Peptide Revenue in Peptide CXO Business (2020-2025)

11.6.5 JPT Peptide Recent Development

11.7 WuXi AppTec

11.7.1 WuXi AppTec Company Details

11.7.2 WuXi AppTec Business Overview

11.7.3 WuXi AppTec Peptide CXO Introduction

11.7.4 WuXi AppTec Revenue in Peptide CXO Business (2020-2025)

11.7.5 WuXi AppTec Recent Development

11.8 Asymchem

11.8.1 Asymchem Company Details

11.8.2 Asymchem Business Overview

11.8.3 Asymchem Peptide CXO Introduction

11.8.4 Asymchem Revenue in Peptide CXO Business (2020-2025)

11.8.5 Asymchem Recent Development

11.9 Jiangsu Sinopep-Allsino Biopharmaceutical

11.9.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Details

11.9.2 Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview

11.9.3 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Introduction

11.9.4 Jiangsu Sinopep-Allsino Biopharmaceutical Revenue in Peptide CXO Business (2020-2025)

11.9.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development

11.10 Chinese Peptide Company

11.10.1 Chinese Peptide Company Company Details

11.10.2 Chinese Peptide Company Business Overview

11.10.3 Chinese Peptide Company Peptide CXO Introduction

11.10.4 Chinese Peptide Company Revenue in Peptide CXO Business (2020-2025)

11.10.5 Chinese Peptide Company Recent Development

11.11 AmbioPharm

11.11.1 AmbioPharm Company Details

11.11.2 AmbioPharm Business Overview

11.11.3 AmbioPharm Peptide CXO Introduction

11.11.4 AmbioPharm Revenue in Peptide CXO Business (2020-2025)

11.11.5 AmbioPharm Recent Development

11.12 ReaLi Tide Biological Technology

11.12.1 ReaLi Tide Biological Technology Company Details

11.12.2 ReaLi Tide Biological Technology Business Overview

11.12.3 ReaLi Tide Biological Technology Peptide CXO Introduction

11.12.4 ReaLi Tide Biological Technology Revenue in Peptide CXO Business (2020-2025)

11.12.5 ReaLi Tide Biological Technology Recent Development

11.13 GL Biochem

11.13.1 GL Biochem Company Details

11.13.2 GL Biochem Business Overview

11.13.3 GL Biochem Peptide CXO Introduction

11.13.4 GL Biochem Revenue in Peptide CXO Business (2020-2025)

11.13.5 GL Biochem Recent Development

11.14 Shenzhen JYMed Technology

11.14.1 Shenzhen JYMed Technology Company Details

11.14.2 Shenzhen JYMed Technology Business Overview

11.14.3 Shenzhen JYMed Technology Peptide CXO Introduction

11.14.4 Shenzhen JYMed Technology Revenue in Peptide CXO Business (2020-2025)

11.14.5 Shenzhen JYMed Technology Recent Development

11.15 Chengdu Shengnuo Biotechnology

11.15.1 Chengdu Shengnuo Biotechnology Company Details

11.15.2 Chengdu Shengnuo Biotechnology Business Overview

11.15.3 Chengdu Shengnuo Biotechnology Peptide CXO Introduction

11.15.4 Chengdu Shengnuo Biotechnology Revenue in Peptide CXO Business (2020-2025)

11.15.5 Chengdu Shengnuo Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Jiangsu Sinopep Allsino Biopharmaceutical

Chinese Peptide Company

AmbioPharm

GL Biochem

Shenzhen JYMed Technology

Chengdu Shengnuo Biotechnology

Bicycle

JPT Peptide

ReaLi Tide Biological Technology

List of Tables

Table 1. Global Peptide CXO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CRO

Table 3. Key Players of CMO/CDMO

Table 4. Global Peptide CXO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Peptide CXO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide CXO Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Peptide CXO Market Share by Region (2020-2025)

Table 8. Global Peptide CXO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Peptide CXO Market Share by Region (2026-2031)

Table 10. Peptide CXO Market Trends

Table 11. Peptide CXO Market Drivers

Table 12. Peptide CXO Market Challenges

Table 13. Peptide CXO Market Restraints

Table 14. Global Peptide CXO Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Peptide CXO Market Share by Players (2020-2025)

Table 16. Global Top Peptide CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CXO as of 2024)

Table 17. Ranking of Global Top Peptide CXO Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Peptide CXO Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Peptide CXO, Headquarters and Area Served

Table 20. Global Key Players of Peptide CXO, Product and Application

Table 21. Global Key Players of Peptide CXO, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peptide CXO Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Peptide CXO Revenue Market Share by Type (2020-2025)

Table 25. Global Peptide CXO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Peptide CXO Revenue Market Share by Type (2026-2031)

Table 27. Global Peptide CXO Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Peptide CXO Revenue Market Share by Application (2020-2025)

Table 29. Global Peptide CXO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Peptide CXO Revenue Market Share by Application (2026-2031)

Table 31. North America Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Peptide CXO Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Peptide CXO Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Peptide CXO Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Peptide CXO Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Peptide CXO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Peptide CXO Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Peptide CXO Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Peptide CXO Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Peptide CXO Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Peptide CXO Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Peptide CXO Market Size by Country (2026-2031) & (US$ Million)

Table 46. Polypeptide Company Details

Table 47. Polypeptide Business Overview

Table 48. Polypeptide Peptide CXO Product

Table 49. Polypeptide Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 50. Polypeptide Recent Development

Table 51. Bachem Company Details

Table 52. Bachem Business Overview

Table 53. Bachem Peptide CXO Product

Table 54. Bachem Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 55. Bachem Recent Development

Table 56. LONZA Company Details

Table 57. LONZA Business Overview

Table 58. LONZA Peptide CXO Product

Table 59. LONZA Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 60. LONZA Recent Development

Table 61. Bicycle Company Details

Table 62. Bicycle Business Overview

Table 63. Bicycle Peptide CXO Product

Table 64. Bicycle Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 65. Bicycle Recent Development

Table 66. Pepscan Company Details

Table 67. Pepscan Business Overview

Table 68. Pepscan Peptide CXO Product

Table 69. Pepscan Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 70. Pepscan Recent Development

Table 71. JPT Peptide Company Details

Table 72. JPT Peptide Business Overview

Table 73. JPT Peptide Peptide CXO Product

Table 74. JPT Peptide Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 75. JPT Peptide Recent Development

Table 76. WuXi AppTec Company Details

Table 77. WuXi AppTec Business Overview

Table 78. WuXi AppTec Peptide CXO Product

Table 79. WuXi AppTec Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 80. WuXi AppTec Recent Development

Table 81. Asymchem Company Details

Table 82. Asymchem Business Overview

Table 83. Asymchem Peptide CXO Product

Table 84. Asymchem Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 85. Asymchem Recent Development

Table 86. Jiangsu Sinopep-Allsino Biopharmaceutical Company Details

Table 87. Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview

Table 88. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Product

Table 89. Jiangsu Sinopep-Allsino Biopharmaceutical Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 90. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development

Table 91. Chinese Peptide Company Company Details

Table 92. Chinese Peptide Company Business Overview

Table 93. Chinese Peptide Company Peptide CXO Product

Table 94. Chinese Peptide Company Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 95. Chinese Peptide Company Recent Development

Table 96. AmbioPharm Company Details

Table 97. AmbioPharm Business Overview

Table 98. AmbioPharm Peptide CXO Product

Table 99. AmbioPharm Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 100. AmbioPharm Recent Development

Table 101. ReaLi Tide Biological Technology Company Details

Table 102. ReaLi Tide Biological Technology Business Overview

Table 103. ReaLi Tide Biological Technology Peptide CXO Product

Table 104. ReaLi Tide Biological Technology Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 105. ReaLi Tide Biological Technology Recent Development

Table 106. GL Biochem Company Details

Table 107. GL Biochem Business Overview

Table 108. GL Biochem Peptide CXO Product

Table 109. GL Biochem Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 110. GL Biochem Recent Development

Table 111. Shenzhen JYMed Technology Company Details

Table 112. Shenzhen JYMed Technology Business Overview

Table 113. Shenzhen JYMed Technology Peptide CXO Product

Table 114. Shenzhen JYMed Technology Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 115. Shenzhen JYMed Technology Recent Development

Table 116. Chengdu Shengnuo Biotechnology Company Details

Table 117. Chengdu Shengnuo Biotechnology Business Overview

Table 118. Chengdu Shengnuo Biotechnology Peptide CXO Product

Table 119. Chengdu Shengnuo Biotechnology Revenue in Peptide CXO Business (2020-2025) & (US$ Million)

Table 120. Chengdu Shengnuo Biotechnology Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Peptide CXO Picture

Figure 2. Global Peptide CXO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide CXO Market Share by Type: 2024 VS 2031

Figure 4. CRO Features

Figure 5. CMO/CDMO Features

Figure 6. Global Peptide CXO Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Peptide CXO Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. Biotech Companies and Research Institutions Case Studies

Figure 10. Peptide CXO Report Years Considered

Figure 11. Global Peptide CXO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Peptide CXO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Peptide CXO Market Share by Region: 2024 VS 2031

Figure 14. Global Peptide CXO Market Share by Players in 2024

Figure 15. Global Peptide CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Peptide CXO Revenue in 2024

Figure 17. North America Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Peptide CXO Market Share by Country (2020-2031)

Figure 19. United States Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Peptide CXO Market Share by Country (2020-2031)

Figure 23. Germany Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Peptide CXO Market Share by Region (2020-2031)

Figure 31. China Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Peptide CXO Market Share by Country (2020-2031)

Figure 39. Mexico Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Peptide CXO Market Share by Country (2020-2031)

Figure 43. Turkey Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Polypeptide Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 47. Bachem Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 48. LONZA Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 49. Bicycle Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 50. Pepscan Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 51. JPT Peptide Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 52. WuXi AppTec Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 53. Asymchem Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 54. Jiangsu Sinopep-Allsino Biopharmaceutical Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 55. Chinese Peptide Company Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 56. AmbioPharm Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 57. ReaLi Tide Biological Technology Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 58. GL Biochem Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 59. Shenzhen JYMed Technology Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 60. Chengdu Shengnuo Biotechnology Revenue Growth Rate in Peptide CXO Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pharmaceutical CXO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Drug CDMO Market Research Report 2024

Global Custom Peptide CDMO Services Market Research Report 2024

Global Peptide Synthesis CDMO Services Market Research Report 2024

Global Peptide API CDMO Services Market Research Report 2025

Global Biopharmaceutical CXO Market Research Report 2024

Global Peptide Manufacturing and Development Services Market Research Report 2024

Global Biologics CXO Services Market Research Report 2024

Global Pharmaceutical Contract Service Outsourcing Market Research Report 2024

Global Chemical Drug CXO Services Market Research Report 2024

Global Medical CXO Services Market Research Report 2024

Global Pharmaceutical CRO Services Market Research Report 2024

Global Biologics and Biosimilars CXO Services Market Research Report 2024

Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Contract Research Organisations CROs Market Research Report 2024

Contract Research Organization CRO and CDMO for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Drug Conjugates PDCs CDMO Service Market Research Report 2024

Global Chemical Drug CMO Market Research Report 2024

Global Oligonucleotide CDMO and CRDMO Services Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions